About Ykbioventures.com
Ykbioventures.com is a venture capital firm founded in 2022. It is primarily based out of Burlingame, United States. As of Oct 2026, Ykbioventures.com is an active investor, having invested in 5 companies, with 4 new investments in the last 12 months. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Consumer. Most recently it participated in the $***** Post IPO round of Bolt Biotherapeutics Overall, Ykbioventures.com portfolio has seen 1 IPO, namely Bolt Biotherapeutics. A lot of funds co-invest with Ykbioventures.com, with names like Lilly sharing a substantial percentage of its portfolio.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B, Post IPO & 1 more
Portfolio IPOs
Portfolio Soonicorns
Deals in last 12 months
Ykbioventures.com's List of All Investments
Ykbioventures.com has a portfolio of 5 companies. Their most notable investmentis in MoonwalkTheir portfolio spans across and United States. They have invested in Life Sciences, High Tech, Consumer and 1 other sectors, across stages such as Series B, Post IPO and 1 more. Here is the list of all investments by Ykbioventures.com:
1. Moonwalk
Digital platform pioneering precision epigenetic medicines. The company has developed a differentiated approach to mapping the epigenome of cellular states at the whole genome, single cell resolution level, as well as proprietary strategies for precise epigenetic engineering.
Key facts about Moonwalk
- Founded Year: 2022
- Location: San Francisco (United States)
- Stage: Series B
- Total Funding till date: $127M
- Employee Count: 21 as on Sep 30, 2026
- Investors: Alpha Wave Global, Lilly and 6 Others
- Latest Funding Round: Series B, Aug 26, 2026, $*****
- Highlight: Editors' Pick
Developer of therapeutics for hair loss treatment in men and women. It provides a topical, non-invasive small molecule pharmacological platform that can be used to activate hair follicle stem cells and promote thick hair growth.
Key facts about Pelage Pharmaceuticals
- Founded Year: 2018
- Location: Los Angeles (United States)
- Stage: Series B
- Total Funding till date: $151M
- Employee Count: 18 as on Sep 30, 2026
- Investors: Arch Venture Partners, Google Ventures and 3 Others
- Latest Funding Round: Series B, Sep 18, 2025, $*****
- Highlight: Editors' Pick
Developer of precision medicine for the treatment of cancer. The company has a molecular glue discovery platform to regulate disease targets powered by high-resolution structural insights, and computational tools for cancer indications.
Key facts about TRIANA Biomedicines
- Founded Year: 2021
- Location: Waltham (United States)
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $163M
- Employee Count: 66 as on Sep 30, 2026
- Investors: Atlas Venture, RA Capital Management and 11 Others
- Latest Funding Round: Series B, Nov 26, 2025, $*****
- Highlight: Editors' Pick
Developer of T-cell therapies for the treatment of cancer. The proprietary platform Boltbody immune-stimulating antibody conjugate has an approach to design anti-tumor therapeutics. The product pipeline includes BDC-3042 which is Dectin-2 agonist antibody that works by repolarizing immune cells from tumor-supportive to tumor-destructive
Key facts about Bolt Biotherapeutics
- Founded Year: 2015
- Location: Redwood City (United States)
- Annual Revenue: $1M - $10M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $177M
- Employee Count: 42 as on Sep 30, 2026
- Investors: RA Capital Management, Curie.Bio and 19 Others
- Latest Funding Round: Post IPO, Oct 23, 2026, $*****
- Highlight: Public
5. Psithera
Online retailer of plant-based products focused on health and wellness. It provides plant-derived items through its online platform. The company focuses on wellness products. It manufactures and sells these products directly to consumers.
Key facts about Psithera
- Founded Year: 2022
- Location: Watertown (United States)
- Stage: Series A
- Total Funding till date: $47.5M
- Employee Count: 34 as on Sep 30, 2026
- Investors: Samsara BioCapital, Roivant Sciences and 3 Others
- Latest Funding Round: Series A, Dec 10, 2025, $*****
Ykbioventures.com's Year-on-Year Investment Trends
In 2025, it made 3 investments, while as of Oct 2026, it has made 2 investments in this year. Its most recent first time investment was in Bolt Biotherapeutics.Ykbioventures.com's Investments by Stage
Ykbioventures.com has made 3 investments in Series B stage with an average round size of $123M, 1 investment in Post IPO stage with an average round size of $120M and 1 investment in Series A stage with an average round size of $47.5M.Stage of entry | No. of Investments |
|---|---|
Series B | 3 |
Post IPO | 1 |
Series A | 1 |
Note: We have considered here, only first round of investments
Ykbioventures.com's Investments by Sector
Ykbioventures.com has a diverse portfolio, with companies operating in the Life Sciences, Consumer, HealthTech and High Tech. Notably, it has invested in 5 Tech companies, 4 Enterprise (B2B) companies, 1 Consumer (B2C) company and at least 1 company focusing on Marketplace.Sector | No. of Investments |
|---|---|
Life Sciences | 4 |
Consumer | 1 |
HealthTech | 1 |
High Tech | 1 |
Note: We have considered here, only first round of investments
Ykbioventures.com's Investments by Geography
Ykbioventures.com has made most investments in United States (5).Ykbioventures.com's recent investments
Ykbioventures.com has made 2 investments in 2026 so far - Bolt Biotherapeutics and Moonwalk.Here are the most recent investments by Ykbioventures.com:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Oct 23, 2026 | United States | Post IPO | 7990 | [+10] | |
Aug 26, 2026 | United States | Series B | 9947 | [+5] | |
Dec 10, 2025 | United States | Series A | 1091 | [+3] | |
Nov 26, 2025 | United States | Series B | 6342 | [+9] | |
Sep 18, 2025 | United States | Series B | 1780 |
IPOs and Publicly Listed companies in Ykbioventures.com's Portfolio
1 of Ykbioventures.com's portfolio company became public - Bolt Biotherapeutics. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Feb 2021 at marketcap of $690MHere are Ykbioventures.com's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Feb 05, 2021 | Oct 23, 2026 | Post IPO | 1026 |
Co-investors of Ykbioventures.com
Over the past year, 45 investors have co-invested in Ykbioventures.com's portfolio companies. This includes only funds.
- Invested before Ykbioventures.com: Google Ventures, Pfizer Venture Investments and 17 others have invested in rounds before Ykbioventures.com. There are 2 companies where Google Ventures has invested before Ykbioventures.com and 2 companies where Pfizer Venture Investments has invested before Ykbioventures.com.
- Top Co-investors of Ykbioventures.com: 26 investors entered a company along with Ykbioventures.com. These include investors like Lilly (1 company).
Recent News related to Ykbioventures.com
•
Series B financing at Normunity to advance T-cell engager into clinicBioWorld•Jan 13, 2025•Normunity, Samsara BioCapital, Enavate Sciences, Regeneron Ventures and 9 others
•
Think Bioscience raises $26M to find ‘pockets’ for drug therapiesDailycamera•May 09, 2024•Think Bioscience, Ykbioventures.com
